Integral BioSystems to Highlight Formulation Development Expertise


Boston-area drug developer to display at Table 117

Integral BioSystems, a Boston area contract research organization (CRO) specializing in innovative pharmaceutical formulation development, will be in the spotlight as a participating exhibitor at Table #117 during the Contract Pharma Contracting and Outsourcing Conference and Tabletop Exhibition Thursday, September 27, 2018 at the Hyatt Regency in New Brunswick, NJ.
With over 25 years of experience in all phases of cell and tissue targeted, sustained release pharmaceutical formulation development, the firm’s chief executive officer and president, Dr. Shikha P. Barman, will be on hand to discuss the specific requirements of interested attendees.
“Whether you need a tried-and-true formulation, or one that has never been seen before, Integral BioSystems can deliver,” said Dr. Barman.